Skip to main content
LLY
NYSE Life Sciences

Lilly's Foundayo Beats Novo's Ozempic Pill in Diabetes Analysis

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1,185.7
Mkt Cap
$1.115T
52W Low
$716.078
52W High
$1,292.65
52W Position info
66% above low
Off High info
8.3% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

LLY sits 66% above its 52-week low of $716.078.

Summary

Lilly released an indirect comparison showing its oral obesity drug Foundayo at 17.2 mg provides 1.5% to 2.4% greater weight loss and 0.3% to 0.6% larger A1C reductions than Novo Nordisk's 25 mg oral semaglutide in type 2 diabetes patients. The analysis uses data from two prior late-stage studies, not a head-to-head trial. Novo's 25 mg dose is not yet approved in the US, with an FDA decision expected by end of 2026. This strengthens Lilly's competitive positioning in the GLP-1 market, though the comparison is in diabetes, not obesity, and Novo disputes the relevance. The news follows Lilly's Q2 beat and FDA approval of Foundayo, adding a new data point in the ongoing rivalry.

At the time of this announcement, LLY was trading at $1,185.70 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.1T. The 52-week trading range was $716.08 to $1,292.65. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 17, 2026, 11:18 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,416.23
Real-time Price: $1,399.00 info
Change: -$17.22 (-1%) info
Market Cap: $1.315T info
LLY
Nov 16, 2026, 6:52 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,455.36
Real-time Price: $1,399.00 info
Change: -$56.36 (-4%) info
Market Cap: $1.315T info
LLY
Nov 12, 2026, 8:30 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $1,452.70
Real-time Price: $1,399.00 info
Change: -$53.69 (-4%) info
Market Cap: $1.315T info
LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,399.00 info
Change: -$48.85 (-3%) info
Market Cap: $1.315T info
LLY
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1,411.12
Real-time Price: $1,399.00 info
Change: -$12.12 (-0.86%) info
Market Cap: $1.315T info